Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Highly Active Hydrogen Evolution Achieved by Microwave-Assisted Rapid Anchoring of Single Platinum Atom on S-Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub>.

ChemSusChem·2026
Same author

Rheology of MXene-reinforced dual-network hydrogels in swollen and unswollen states.

Soft matter·2026
Same author

CT-Based Assessment of Brain Edema May Predict Which Patients with Traumatic Brain Injury May Benefit from Tranexamic Acid.

AJNR. American journal of neuroradiology·2026
Same author

Impact of Imaging Acquisition and Protocol Variability on Artificial Intelligence Model Performance: A Secondary Analysis of the ASFNR Artificial Intelligence Competition.

AJNR. American journal of neuroradiology·2026
Same author

MRI Findings of Intracranial Hemorrhages in ARCADIA-MRI: An Ancillary Study to the ARCADIA Trial.

AJNR. American journal of neuroradiology·2025
Same author

The Latest Advances in Mechanically Robust Self-Healing Polyurea Based on Dynamic Chemistry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

相关实验视频

Updated: Jul 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K

针对CD24作为固体癌症的新型免疫疗法.

Yan Yang1, Guangming Zhu2, Li Yang3

  • 1Xinxiang Engineering Technology Research Center of Tumor-Targeted Drug Development, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, 453000, Henan, China.

Cell communication and signaling : CCS
|November 3, 2023
PubMed
概括

分化集群24 (CD24) 是一种关键的癌症干细胞标记物和固体瘤中的免疫检查点. 向CD24为癌症治疗提供了一个有前途的治疗策略.

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • 分化集群24 (CD24) 是一种高度糖化分子,涉及到癌症干细胞的特性.
  • CD24通过与连接体或通过信号传导通路相互作用而起作用,从而影响瘤的开始和进展.
关键词:
CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24 CD24癌症干细胞 癌症干细胞细胞信号传递 细胞信号传递免疫检查点抑制剂 免疫检查点抑制剂免疫治疗是一种免疫疗法.固体癌症是一种固体癌症.

更多相关视频

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

554

相关实验视频

Last Updated: Jul 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

554